In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods

References

• Senay E. Addictive behaviours and benzodiazepines. 1. Abuse liability and physical dependence. Adv Alcohol Subst Abuse 1989;8:107–24.
   PubMedGoogle Scholar
• Darke S, Hall W, Ross J, Wodak A. Benzodiazepine use and HIV risk-taking behaviour among injecting drug users. Drug Alcohol Depend 1992;31:31–6.
   PubMed Web of Science ®Google Scholar
• Barnas C, Rossmann M, Roessler H, Riemer Y, Fleisch- hacker WW. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 1992;12:397–402.
   Google Scholar
• San L, Tato J, Torrens M et al. Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification. Drug Alcohol Depend 1993;32:281–6.
   Google Scholar
• Ross J, Darke S, Hall W. Transitions between routes of benzodiazepine administration among heroin users in Sydney. Addiction 1997;92:697–705.
   PubMed Web of Science ®Google Scholar
• Klee H, Faugier J, Hayes C, Boulton T, Morris J. AIDS related risk behaviour, poly-drug use and temazepam. Br J Addict 1990;85:1125–32.
   PubMedGoogle Scholar
• Darke S, Swift W, Hall W, Ross M. Drug use, HIV risk- taking and psychosocial correlates of benzodiazepine use among methadone maintenance clients. Drug Alcohol Depend 1993;Dec; 34:67–70.
   Google Scholar
• Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev 2002;21:27–32.
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: 1. Prevalence and correlates of non-fatal overdose. Addiction 1996;9:405–11.
   Google Scholar
• McGregor C, Darke S, Ali R, Christie P. Experience of non-fatal overdose among heroin users in Adelaide, Australia: circumstances and risk perceptions. Addiction 1998;93:701–11.
   PubMed Web of Science ®Google Scholar
• McGregor C, Ali R, Lokan R, Christie P, Darke S. Accidental fatalities among heroin users in South Australia, 1994-1997: toxicological findings and circumstances of death. Addict Res Theory 2002;10:335–46.
   Web of Science ®Google Scholar
• Zador D, Sunjic S, Darke S. Heroin-related deaths in New South Wales, 1992: toxicological findings and circum- stances. Med J Aust 1996;164:204–7.
   PubMed Web of Science ®Google Scholar
• Zador D, Sunjic S. Methadone-related deaths and mortality rate during induction into methadone maintenance, New South Wales, 1996. Drug Alcohol Rev 2002;21:131–6.
   PubMed Web of Science ®Google Scholar
• Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict 1987;82:665–71.
   PubMedGoogle Scholar
• Busto U, Sykora K, Sellers EM. A clinical scale to assess benzodiazepine withdrawal. J Clin Pharmacol 1989;9:412–16.
   Google Scholar
• Tyrer P, Murphy S, Riley P. The Benzodiazepine With- drawal Symptom Questionnaire. J Affect Disord 1990;19:53–61.
   PubMed Web of Science ®Google Scholar
• Harrison M, Busto U, Naranjo CA, Kaplan HL, Sellers MD. Diazepam tapering in detoxification for high-dose benzodiazepine abuse. Clin Pharmacol Ther 1984;36:527–33.
   PubMedGoogle Scholar
• Saitz R, Mayo-Smith MF, Roberts MS et al. Individualized treatment for alcohol withdrawal. JAMA 1994;272:519–58.
   PubMed Web of Science ®Google Scholar
• Griffiths RR, Roache JD. Abuse liability of benzodiazepines: a review of human studies evaluation subjective and/or reinforcing effects. Lancaster, UK: MTP Press Limited, 1985.
   Google Scholar
• Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996;91:39–45.
   PubMed Web of Science ®Google Scholar
• Reid A, Lynskey M, Copeland J. Cannabis use among Australian adolescents: findings of the 1998 National Drug Strategy Household Survey. Aust NZ J Public Health 2000;24:596–602.
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Griffiths P et al. The Severity of Dependence Scale (SDS) in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607–14.
   Google Scholar
• Goodman LS, Gilman AG. The pharmacological basis of therapeutics, 7th edn. New York: MacMillan, 1985.
   Google Scholar
• Ross J, Darke S, Hall W. Benzodiazepine use among heroin users in Sydney: patterns of use, availability and procure- ment. Drug Alcohol Rev 1996;15:237–43.
   PubMed Web of Science ®Google Scholar
• McGregor C, Ali R, Darke S, Christie P. Benzodiazepine use among heroin users in Adelaide, Australia: patterns and preferences. In: Dyer K, Addy D, eds. New perspectives: Proceedings of the 1997 NCETA Research Seminar Program. Adelaide: National Centre for Education and Training on Addiction, 1997.
   Google Scholar
• Ashton H. Protracted withdrawal syndromes from benzo- diazepines. J Subst Abuse Treat 1991;8:19–28.
   PubMed Web of Science ®Google Scholar
• Sindelar J, Fiellin D. Innovations in treatment for drug abuse: solutions to a public health problem. Ann Rev Public Health 2001;22:249–72.
   PubMed Web of Science ®Google Scholar
• Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002;97:963–7.
   PubMed Web of Science ®Google Scholar